Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
· investor relations
AI Briefing
- Sensorion to present at ASGCT Annual Meeting
- Company showcases its expertise in gene therapy development
- Laurent Desire to present Sensorion's preclinical developments
Advertisement